Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer.
about
GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapyXB130-A Novel Adaptor Protein: Gene, Function, and Roles in TumorigenesisXB130: A novel adaptor protein in cancer signal transductionXB130 deficiency affects tracheal epithelial differentiation during airway repairXB130, a new adaptor protein, regulates expression of tumor suppressive microRNAs in cancer cells.XB130 expression in human osteosarcoma: a clinical and experimental study.Expression of XB130 in human ductal breast cancer.XB130 promotes bronchioalveolar stem cell and Club cell proliferation in airway epithelial repair and regeneration.XB130 deficiency enhances lipopolysaccharide-induced septic response and acute lung injury.XB130 promotes proliferation and invasion of gastric cancer cellsPrognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinomaXB130 is overexpressed in prostate cancer and involved in cell growth and invasion.miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.Knockdown Inhibits the Proliferation, Invasiveness, and Metastasis of Hepatocellular Carcinoma Cells and Sensitizes them to TRAIL-Induced Apoptosis
P2860
Q21245490-49D395C4-FBD6-45CE-A61A-3CECE26B4EA1Q28388570-9B76ED55-B01C-49B1-A94B-FB9FCC4C4C1AQ28388581-FABB50DC-69DA-422A-ABBC-896A5E15462FQ28395217-2A8F1CA4-BDED-4653-9387-47C094C5C815Q34335185-00802E7E-2F0D-4C4A-A52E-0CEB8DF4DB3AQ35632091-988CC7BD-2EE1-4273-AB23-D24296507559Q35854139-73509155-30D4-4B5D-95CD-1822BC63AFC2Q36544425-43A9ABA3-DE0D-48E2-8427-A2F7326949FEQ37295366-7E415834-3E87-44FC-A63E-391AA5B20C3CQ37441280-44F45309-0101-4255-B8C9-A049CEF42FAEQ37717226-266D5A11-5F04-4FF7-AE29-261D16CF49B6Q38752716-3F2FD2AF-F9A7-482A-BEF1-CA2273998868Q38859854-221C56AB-F490-41E7-93B7-F15756778137Q39185898-6B1D2A1C-4031-4662-A234-9D9A81623FB6Q55110365-69D12BC0-A91C-4589-AD15-7D989E6BBD19Q56979446-9BDF4E7C-3545-4931-AED5-D9E0C043C062
P2860
Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@ast
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@en
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@nl
type
label
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@ast
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@en
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@nl
prefLabel
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@ast
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@en
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@nl
P2093
P2860
P1433
P1476
Silencing of XB130 is associat ...... sensitivity of gastric cancer.
@en
P2093
Dayong Zheng
Wangjun Liao
Weizhen Huang
Yulin Liao
P2860
P304
P356
10.1371/JOURNAL.PONE.0041660
P407
P577
2012-08-23T00:00:00Z